Qube Research & Technologies (QRT)
PAHC icon

Qube Research & Technologies (QRT)’s Phibro Animal Health PAHC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69M Sell
181,127
-27,322
-13% -$1.15M 0.01% 1571
2026
Q1 		$11.5M Sell
208,449
-83,324
-29% -$3.97M 0.01% 1194
2025
Q4 		$10.9M Buy
291,773
+36,420
+14% +$1.48M 0.01% 1293
2025
Q3 		$10.3M Buy
255,353
+73,231
+40% +$2.42M 0.01% 1305
2025
Q2 		$4.65M Buy
182,122
+33,548
+23% +$732K ﹤0.01% 1752
2025
Q1 		$3.17M Buy
148,574
+94,251
+174% +$2.11M ﹤0.01% 1758
2024
Q4 		$1.14M Buy
+54,323
New +$1.26M ﹤0.01% 2119
2024
Q1 		– Sell
-8,904
Closed -$103K – 4769
2023
Q4 		$103K Buy
8,904
+6,231
+233% +$70.3K ﹤0.01% 3085
2023
Q3 		$34.1K Buy
+2,673
New +$37.9K ﹤0.01% 2980

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PAHC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Phibro Animal Health (PAHC) stake by 13% in Q2 2026, selling an estimated $1.15M and leaving 181,127 shares worth $5.69M. The position accounts for 0.01% of the portfolio, ranked #1571.

Qube Research & Technologies (QRT) first reported a position in PAHC in Q3 2023 and has held it in 9 quarters since. The position peaked at $11.5M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Qube Research & Technologies (QRT) held 181,127 shares of Phibro Animal Health worth $5.69M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 27,322 Phibro Animal Health shares in Q2 2026, an estimated $1.15M.
  • Phibro Animal Health made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1571 holding.
  • Qube Research & Technologies (QRT) first reported a position in Phibro Animal Health in Q3 2023 and has held it in 9 quarters since.
  • Qube Research & Technologies (QRT)'s Phibro Animal Health position peaked at $11.5M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.